Menu

Study: IVF Media Affects Treatment Outcomes

Differences between cultures used for in vitro fertilization techniques can impact fertility and offspring health, researchers report.

Aug 24, 2016
Ben Andrew Henry

WIKIMEDIA, UMBERTO SALVAGNIN

Experts have been divided over whether the culture media in which eggs are fertilized during in vitro fertilization (IVF) have lasting impacts on embryonic development. In a paper published in Human Reproduction this week (August 23), researchers from the Maastricht University Medical Center in the Netherlands and their colleagues detail the first randomized controlled trial to compare two IVF culture media, finding that one of the preparations created more viable embryos and higher fertility rates than the other. Babies born using this culture also weighed about a third of a pound less, the team found. “It’s reasonable to believe that different media compositions can affect embryo development,” David Ball, an embryology lab director in Seattle who was not involved in the trial, told STAT News.

The clinics involved in the study stopped using the culture shown to produce fewer viable embryos, STAT reported, but the study only compared two of the roughly 20 IVF culture media commercially available.

The difficulty clinics face in choosing IVF media is bolstered by the fact that companies that produce cultures are not required to list the exact compositions of their products. The labels on culture media give ingredients without exact proportions, the researchers noted in their paper. Now that it’s known that this substrate can affect fertility and offspring health, “not knowing the exact composition of their IVF culture media is no longer an option for clinical embryologists,” Hans Evers, editor in chief of Human Reproduction, wrote in an accompanying editorial.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.